Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.

Detailed Quote for Roche Holding Ltd ADR (Sponsored) (RHHBY)

Detailed Quote for Roche Holding Ltd ADR (Sponsored) (RHHBY)

Sector News | Topic News
News for Roche Holding Ltd ADR (Sponsored) (RHHBY)
Tue, Mar 26, 2019
12:27 PM Biogen: The End Of The Amyloid Era For Alzheimer's Disease? - SeekingAlpha
12:21 PM Trump reaches across the aisle on drug prices - SeekingAlpha
7:35 AM Biotech M&A Theme Builds Momentum - SeekingAlpha
Mon, Mar 25, 2019
2:26 PM In The Wake Of Biogen's Alzheimer's Failure, Who Do We Turn Our Attention To Now? - SeekingAlpha
Fri, Mar 22, 2019
1:52 AM Investment Process Special (Part 3 Of 3): ROIC As A Basis For Value Investing With Roche And Cognizant - SeekingAlpha
Thu, Mar 21, 2019
1:08 PM Some Thoughts On Biogen's Drop - SeekingAlpha
10:00 AM Roche launches NAVIFY Mutation Profiler and NAVIFY Therapy Matcher to support comprehensive genomic profiling in cancer - PR Newswire
7:16 AM Levi Strauss' $6.2B Return Public (Wall Street Breakfast Podcast) - SeekingAlpha
7:04 AM Wall Street Breakfast: Levi Strauss' $6.2B Return Public - SeekingAlpha
6:00 AM An Unexpected Halt In Multiple Myeloma For Venetoclax - SeekingAlpha
4:53 AM Roche suing former execs for fraud - SeekingAlpha
Wed, Mar 20, 2019
2:14 PM Biotech Analysis Central Pharma News: AbbVie's Trouble, Merck KGaA's Bad Streak, Puma's Positive Data - SeekingAlpha
12:54 PM Roche Looks To Expand MabThera's Reach In Wake Of Reduced Herceptin Sales - SeekingAlpha
12:24 PM Why T2 Biosystems Is A Potential 10X Bagger - SeekingAlpha
9:43 AM Roche: Spark Deal Pricey But Accretive - SeekingAlpha
Tue, Mar 19, 2019
9:10 AM AbbVie down 1% premarket on partial hold on venetoclax - SeekingAlpha
2:00 AM FDA approves Roche's Tecentriq in combination with chemotherapy for the initial treatment of adults with extensive-stage small cell lung cancer - Thomson Reuters ONE
Mon, Mar 18, 2019
9:15 PM FDA Approves Genentech's Tecentriq in Combination With Chemotherapy for the Initial Treatment of Adults With Extensive-Stage Small Cell Lung Cancer - Business Wire
Fri, Mar 15, 2019
11:39 AM Stocks to Watch: Roche Holding Ltd ADR (Sponsored) (OTCQX:RHHBY) Up +1.66% Thursday - StreetSignals
2:00 AM European Commission approves Roche's MabThera (rituximab) for a rare autoimmune disease - Thomson Reuters ONE
More News for RHHBY >>